fibrinogen has been researched along with Hepatitis B, Chronic in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alberio, L; Artru, F; Casini, A; Chtioui, H; Fraga, M; Moradpour, D; Neerman-Arbez, M; Romailler, E; Schneider, A; Sempoux, C; Tschopp, J | 1 |
| Abed, SY; El-Mesery, A; El-Mesery, M; El-Mowafy, M; Elgaml, A; Youssef, LF | 1 |
| Binh, MT; Hoan, NX; Meyer, CG; Quyen, DT; Quyet, D; Son, HA; Song, LH; Toan, NL; Van Ba, N; Van Luong, H; Van Tong, H; Velavan, TP | 1 |
| Huang, L; Li, G; Wu, J; Yu, Y; Yuan, T | 1 |
| Gao, H; Jiang, L; Liu, C; Qin, R; Wang, M; Xiao, G; Yan, L; Yang, J; Ye, D; Zhang, H; Zhu, F | 1 |
| Liu, Y; Ning, Q; Wang, X; Wu, D; Xu, L; Yang, D | 1 |
| Cao, D; Chen, Y; Fei, L; Guo, G; Ruan, Z; Wu, Y; Xie, Z; Xu, H | 1 |
| Gornjakovic, S; Mesihovic, R; Prohic, D; Saray, A; Vanis, N | 1 |
| Abdo, AA; Gader, AG; Saja, MF; Sanai, FM; Shaikh, SA | 1 |
| Chen, Y; Hao, LJ; Ning, Q; Sun, Y; Wang, BJ; Xi, D; Yan, FM; Yan, WM; Zhang, DS | 1 |
| Chen, Y; Hao, LJ; Luo, XP; Ning, Q; Tao, XX; Xi, D; Yan, FM; Yan, WM; Zhu, F | 1 |
| Bai, J; Cong, YL; Wei, YX; Yin, ZJ; Zhang, LW | 1 |
| Dymek, G; Kotschy, M; Michalska, K; Szaflarska-Popławska, A | 1 |
| Başkol, M; Eser, B; Gürsoy, S; Güven, K; Ozbakir, O; Soyuer, I; Torun, E; Yücesoy, M; Yurci, A | 1 |
| Abdel Gader, AG; Al Faleh, FZ; Al Ghumlas, AK | 1 |
1 trial(s) available for fibrinogen and Hepatitis B, Chronic
| Article | Year |
|---|---|
The coagulopathy of liver disease: does vitamin K help?
Topics: Adult; Aged; Biomarkers; Blood Coagulation Disorders; Blood Coagulation Tests; Carcinoma, Hepatocellular; Factor VII; Female; Fibrinogen; Hemorrhagic Disorders; Hepatitis B, Chronic; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Protein C; Protein Precursors; Protein S; Prothrombin; Treatment Outcome; Vitamin K; Young Adult | 2013 |
14 other study(ies) available for fibrinogen and Hepatitis B, Chronic
| Article | Year |
|---|---|
Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Diagnosis, Differential; Fibrinogen; Glycogen Storage Disease Type IV; Hepatitis; Hepatitis B, Chronic; Humans; Inclusion Bodies; Lafora Disease; Liver; Liver Function Tests; Male; Middle Aged; Pandemics; Patient Care Management; Pneumonia, Ventilator-Associated; Pneumonia, Viral; Pulmonary Embolism; Respiration, Artificial; SARS-CoV-2; Treatment Outcome | 2020 |
Serum Soluble Fibrinogen-Like Protein 2 Represents a Novel Biomarker for Differentiation Between Acute and Chronic Egyptian Hepatitis B Virus-Infected Patients.
Topics: Acute Disease; Biomarkers; Chronic Disease; Egypt; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Hepatitis B, Chronic; Humans; Male; Middle Aged | 2021 |
Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Carcinoma, Hepatocellular; Case-Control Studies; Disease Progression; Female; Fibrinogen; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Solubility; Young Adult | 2018 |
[hFgl2 protein expression in peripheral blood mononuclear cells in different clinical types of liver disease].
Topics: Case-Control Studies; Fibrinogen; Hepatitis B, Chronic; Humans; Leukocytes, Mononuclear; Liver Neoplasms | 2013 |
Preoperatively staging liver fibrosis using noninvasive method in hepatitis B virus-infected hepatocellular carcinoma patients.
Topics: Adult; Area Under Curve; Bilirubin; Biomarkers; Carcinoma, Hepatocellular; Female; Fibrinogen; Hepatectomy; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Platelet Count; Preoperative Period; Prospective Studies; Prothrombin; Regression Analysis; Retrospective Studies | 2017 |
Inhibitory function of Tregs via soluble FGL2 in chronic hepatitis B.
Topics: CD8-Positive T-Lymphocytes; Cells, Cultured; Fibrinogen; Hepatitis B, Chronic; Humans; T-Lymphocytes, Regulatory | 2012 |
Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure.
Topics: Apoptosis; B7-H1 Antigen; Biomarkers; CD8-Positive T-Lymphocytes; End Stage Liver Disease; Epithelial Cells; Fibrinogen; Hepatitis B virus; Hepatitis B, Chronic; Humans; Killer Cells, Natural; Ligands; Liver; Liver Failure, Acute; Macrophages; Monocytes; Programmed Cell Death 1 Ligand 2 Protein; Programmed Cell Death 1 Receptor; Viral Load | 2013 |
Clinical significance of haemostatic tests in chronic liver disease.
Topics: Adult; Antithrombin III; Biomarkers; Blood Coagulation Tests; Chronic Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; International Normalized Ratio; Liver Cirrhosis; Male; Middle Aged; Partial Thromboplastin Time; Protein C | 2012 |
[Expression of human fibroleukin gene acute on chronic hepatitis B and its clinical significance].
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fibrinogen; Hepatitis B, Chronic; Humans; Immunohistochemistry; Infant; Liver; Male; Necrosis | 2003 |
[Hfgl2/fibroleukin expression in liver and peripheral blood mononuclear cells (PBMC) and its correlation with disease severity].
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fibrinogen; Hepatitis B, Chronic; Humans; Infant; Leukocytes, Mononuclear; Liver; Male; Middle Aged; Prognosis; RNA, Messenger; Severity of Illness Index; T-Lymphocytes | 2004 |
[The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores].
Topics: Adult; Aged; Antithrombins; Blood Coagulation Factors; Female; Fibrinogen; Hemostasis; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Prothrombin Time; Severity of Illness Index | 2005 |
[Activation of fibrynolysis in children with chronic B or C hepatitis].
Topics: Adolescent; alpha-2-Antiplasmin; Antifibrinolytic Agents; Case-Control Studies; Child; Child, Preschool; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Male; Plasminogen Activator Inhibitor 1; Poland; Tissue Plasminogen Activator | 2004 |
Importance of anticoagulant proteins in chronic liver diseases.
Topics: Adult; Aged; Antithrombins; Bilirubin; Biomarkers; Blood Coagulation Factor Inhibitors; Blood Coagulation Tests; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Middle Aged; Protein C; Protein S; Serum Albumin; Severity of Illness Index | 2005 |
Natural anticoagulants and fibrinolytic activity following interferon therapy in chronic viral hepatitis.
Topics: Adult; Antiviral Agents; Biomarkers; Case-Control Studies; Female; Fibrinogen; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatocytes; Humans; Interferon-alpha; Liver; Male; Middle Aged; Protein S; Thrombin Time | 2008 |